These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1233459)

  • 1. [Immunologic prevention of rabies. IV. Experimental evaluation of antigenic efficacy of a vaccine obtained from the brain of suckling rats].
    Mastroeni I; Simonetti AD; D'Arca SU; Tarsitani G; Vescia N
    Nuovi Ann Ig Microbiol; 1975; 26(6):365-78. PubMed ID: 1233459
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunologic prevention of rabies. III. Experimental evaluation of the capacity of an antigen of a vaccine obtained from the brain of suckling mice].
    Vescia N; Mastroeni I; Simonetti AD; D'arca SU; Tarsitani G
    Nuovi Ann Ig Microbiol; 1974; 25(5):307-18. PubMed ID: 4465765
    [No Abstract]   [Full Text] [Related]  

  • 3. [Trials on the antigenicity, protectivity and encephalitogenicity of the Hempt vaccine and considerations on rabies protective vaccination in Germany].
    Kuwert E
    Arch Hyg Bakteriol; 1967 May; 151(1):130-45. PubMed ID: 4386311
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunologic prevention of rabies. I. Experimental evaluation of the antigenic potency of an avianized vaccine].
    D'arca SU; Tarsitani G; Vescia N; Mastroeni I; D'arca Simonetti A
    Nuovi Ann Ig Microbiol; 1974; 25(4):229-39. PubMed ID: 4465762
    [No Abstract]   [Full Text] [Related]  

  • 5. Monoclonal antibody characterization of rabies virus isolates from Russia, Finland and Estonia.
    Metlin AE; Cox J; Rybakov SS; Huovilainen A; Grouzdev KN; Neuvonen E
    J Vet Med B Infect Dis Vet Public Health; 2004 Mar; 51(2):94-6. PubMed ID: 15030608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunological prevention of rabies. II. Experimental evaluation of the antigenic potency of a phenolated vaccine of the Fermi type].
    Tarsitani G; Vescia N; Mastroeni I; D'Arca Simonetti A; D'Arca SU
    Nuovi Ann Ig Microbiol; 1974; 25(4):240-50. PubMed ID: 4465763
    [No Abstract]   [Full Text] [Related]  

  • 7. Live vaccinia-rabies virus recombinants, but not an inactivated rabies virus cell culture vaccine, protect B-lymphocyte-deficient A/WySnJ mice against rabies: considerations of recombinant defective poxviruses for rabies immunization of immunocompromised individuals.
    Lodmell DL; Esposito JJ; Ewalt LC
    Vaccine; 2004 Sep; 22(25-26):3329-33. PubMed ID: 15308356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory investigations on "postvaccinall rabies" caused by live sheep-brain vaccine.
    Wojciechowski KJ
    Acta Microbiol Pol; 1976; 25(2):153-60. PubMed ID: 59530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of an inactivated rabies virus vaccine in domestic ferrets.
    Rupprecht CE; Gilbert J; Pitts R; Marshall KR; Koprowski H
    J Am Vet Med Assoc; 1990 May; 196(10):1614-6. PubMed ID: 2347753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody response to an anti-rabies vaccine in a dog population under field conditions in Bolivia.
    Suzuki K; González ET; Ascarrunz G; Loza A; Pérez M; Ruiz G; Rojas L; Mancilla K; Pereira JA; Guzman JA; Pecoraro MR
    Zoonoses Public Health; 2008 Oct; 55(8-10):414-20. PubMed ID: 18399941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Properties of rabies vaccine freed of neuroallergenic factor from brain tissue.
    Pille ER; Karakuyumchan MK; Nadaichik LV
    Acta Virol; 1981 Sep; 25(5):304-8. PubMed ID: 6118049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic and molecular characterization of field and vaccine rabies virus strains in the Russian Federation.
    Metlin AE; Rybakov SS; Gruzdev KN; Neuvonen E; Cox J; Huovilainen A
    Dev Biol (Basel); 2006; 125():33-7. PubMed ID: 16878458
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antigenicity of anti-rabies vaccine inactivated by acetyl-ethylen-imine, beta-propiolactone and phenol].
    Cunha RG; Da Silva RA
    Rev Bras Biol; 1971 Dec; 31(4):435-40. PubMed ID: 5173322
    [No Abstract]   [Full Text] [Related]  

  • 14. Rabies vaccine: traditional and novel approaches.
    Kieny MP; Desmettre P; Soulebot JP; Lathe R
    Prog Vet Microbiol Immunol; 1987; 3():73-111. PubMed ID: 3078836
    [No Abstract]   [Full Text] [Related]  

  • 15. [Serological evaluation of the efficacy of an antirabies vaccine in field dogs in Tunisia].
    Haddad N
    Ann Rech Vet; 1987; 18(1):63-7. PubMed ID: 3579184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Humoral immune response as a laboratory criterion for evaluation of the effectiveness of rabies vaccines].
    Seroka D; Wysokińska T
    Med Dosw Mikrobiol; 1982; 34(1-2):61-71. PubMed ID: 7144329
    [No Abstract]   [Full Text] [Related]  

  • 17. Rabies postexposure prophylaxis with human diploid cell rabies vaccine: lower neutralizing antibody titers with Wyeth vaccine.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Feb; 34(7):90-2. PubMed ID: 3918250
    [No Abstract]   [Full Text] [Related]  

  • 18. Histamine level in the central nervous system in experimental rabies infection and immunization.
    Shokeir AA; Taha AM
    Z Immunitatsforsch Exp Klin Immunol; 1972 Mar; 143(2):206-8. PubMed ID: 4282798
    [No Abstract]   [Full Text] [Related]  

  • 19. [Rabies vaccine].
    Morimoto K; Takayama-Ito M
    Nihon Rinsho; 2005 May; 63 Suppl 5():654-8. PubMed ID: 15954425
    [No Abstract]   [Full Text] [Related]  

  • 20. A DNA vaccine that encodes rabies virus glycoprotein lacking transmembrane domain enhances antibody response but not protection.
    Gupta PK; Sharma S; Walunj SS; Patil AA; Rai A; Saini M
    Acta Virol; 2006; 50(2):87-92. PubMed ID: 16808325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.